Kairos Ventures closes third fund at $58 million


venture capital

Kairos Ventures is a Los Angeles-based venture capital firm that invests in life sciences and physical technology. It closed its third fund with $58M.

Fund III made 27 investments in companies like:

  • Vivodyne, a bioengineering company creating fully-vascularized human organoids (“organs-on-chip”) and can deploy them in fully automated instruments conducting thousands of experiments at a time;
  • PteroDynamics is an aircraft design and manufacturing company which has developed and patent a unique drone with folding wings.
  • Linnaeus, an early stage biotech company that studies and develops cancer treatments using the signaling of the female sexhormone as a defense against cancer.

The funds remaining will be used primarily to support existing investments.

Founded in 2015 by Jim Demetriades, Kairos Ventures works closely with the world’s top patent-producing universities and research institutions to identify and support the commercialization of transformative discoveries into sustainable and successful businesses. The firm has invested in more than 55 companies since its inception. It works side-by-side and with Nobel Prize and Lasker Award recipients, engineers, and entrepreneurs to help them realize all their scientific and business potential.

Get latest news from African Startup ecosystem

Latest stories

You might also like...